Evidence map›Paper›PMID 42689922›Full record

ArticleJACC. Case reports2026

Finding NEMO (Nuanced Effective Medical Options) for Personalized Cholesterol Management.

Yakubu Bene-Alhasan, Layla A Abushamat, Vijay Nambi

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yakubu Bene-AlhasanSection of Cardiovascular Research, Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA.
Layla A AbushamatSection of Cardiovascular Research, Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA.
Vijay NambiSection of Cardiovascular Research, Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA; Michael E. DeBakey Veterans Affairs Hospital, Houston, Texas, USA. Electronic address: vnambi@bcm.edu.

Funding

Mechanisms and consequences of erythritol and erythronate excess in cardiometabolic diseaseK23DK140641 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Layla A Abushamat · 2024 to 2026
$583k
NIDDK NIH HHS K23 DK140641
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

dyslipidemiasgenetic disordersprimary prevention

Identifiers

PMID42689922
PMCPMC13554884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.